Corrigendum: A Unique Peptide Deformylase Platform to Rationally Design and Challenge Novel Active Compounds

Scientific Reports - United Kingdom
doi 10.1038/srep39365
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Structure and Activity of Human Mitochondrial Peptide Deformylase, a Novel Cancer Target

2009English

Design and Synthesis of Macrocyclic Peptidyl Hydroxamates as Peptide Deformylase Inhibitors

Bioorganic and Medicinal Chemistry Letters
Organic ChemistryMolecular MedicineMolecular BiologyBiochemistryClinical BiochemistryPharmaceutical ScienceDrug Discovery
2008English

Single-Dose Safety, Tolerability, and Pharmacokinetics of the Antibiotic GSK1322322, a Novel Peptide Deformylase Inhibitor

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2013English

Microbiome Changes in Healthy Volunteers Treated With GSK1322322, a Novel Antibiotic Targeting Bacterial Peptide Deformylase

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2014English

Design and Evaluation of a Novel Class-Directed 2D Fingerprint to Search for Structurally Diverse Active Compounds

English

Design and Synthesis of Novel Potent Non-Peptide and Orally Active Renin Inhibitors

Acta Crystallographica Section A Foundations of Crystallography
1996English

A Microfluidic Platform for the Characterisation of CNS Active Compounds

Scientific Reports
Multidisciplinary
2017English

A Novel Approach to Peptide Vaccine Design for Ebola Virus

2019English

Evaluation of LBM415 (NVP PDF-713), a Novel Peptide Deformylase Inhibitor, for Treatment of Experimental Mycoplasma Pneumoniae Pneumonia

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy